Truinject Corp. v. Nestle Skin Health, S.A., et al
| 1:2019cv00592 |
| December 13, 2019 |
| US District Court for the District of Delaware |
| Wilmington Office |
| Patent |
| 35 U.S.C. ยง 0145 |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
780
MEMORANDUM ORDER: IT IS HEREBY ORDERED that Judge Hall's September 14, 2021 Memorandum Order recommending that the Court deny Plaintiff's motion for leave to amend the complaint and deny Plaintiff's motion to compel discovery is ADOPTED for the reasons stated by Judge Hall. Signed by Judge Gregory B. Williams on 9/15/23. (ntl)
|
|
Filing
264
MEMORANDUM ORDER: IT IS HEREBY ORDERED that Plaintiff's Objection (D.I. 225) is OVERRULED and the Report (D.I. 224) is ADOPTED. IT IS FURTHER ORDERED that Judge Hall's 8/28/2020 Report and Recommendation (D.I. 250) is ADOPTED. Defendants ' motion (D.I. 215) is GRANTED with respect to Count VIII and DENIED with respect to Count XVI. Count VIII is DISMISSED without prejudice to Plaintiffs filing another amended complaint, solely to amend Count VIII. Such amendment must be filed no later than December 11, 2020. Signed by Judge Leonard P. Stark on 11/20/2020. (etg)
|
|
Filing
250
REPORT AND RECOMMENDATIONS re 215 Motion to Dismiss for Failure to State a Claim Pursuant to Fed. R. Civ. P. 12(b)(6) filed by Galderma Laboratories L.P., Galderma S.A., SHDS, Inc. Please note that when filing Objections pursuant to Fed eral Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. (*Objections to R&R due by 9/11/2020). Signed by Judge Jennifer L. Hall on 8/28/2020. (ceg)
|
|
Filing
224
REPORT AND RECOMMENDATIONS re: Markman Hearing and Claim Construction. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. (*Objections to R&R due by 7/2/2020). Signed by Judge Jennifer L. Hall on 6/18/2020. (ceg)
|
|
Filing
193
MEMORANDUM ORDER re 169 REPORT AND RECOMMENDATION and 178 REPORT AND RECOMMENDATION are ADOPTED re pending motions to dismiss (D.I. 117, 119, 121, 123, and 125) (See Order for further details). Signed by Judge Leonard P. Stark on 3/17/20. (ntl)
|
|
Filing
178
REPORT AND RECOMMENDATIONS re 117 Motion to Dismiss for Failure to State a Claim filed by Galderma Laboratories L.P., Galderma S.A.; 119 Motion to Dismiss for Failure to State a Claim filed by Raetzman, Lopez, McCrea, and Lask; 121 Mot ion to Dismiss for Failure to State a Claim filed by Nestle Skin Health, Inc.; and 125 Motion to Dismiss for Failure to State a Claim filed by John Rogers. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. (*Objections to R&R due by 1/21/2020). Signed by Judge Jennifer L. Hall on 1/7/2020. (ceg)
|
|
Filing
169
REPORT AND RECOMMENDATIONS re 123 Motion to Dismiss for Lack of Jurisdiction Over the Person filed by Nestle Skin Health S.A. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists so lely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. (*Objections to R&R due by 12/27/2019). Signed by Judge Jennifer L. Hall on 12/13/2019. (ceg)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Truinject Corp. v. Nestle Skin Health, S.A., et al | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
